Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-06

Clinical Trial Update: Daptomycin > 6 mg/kg/Day as Salvage Therapy in Patients With Complex Bone and Joint Infection: Cohort Study in a Regionalreference Center

View source ↗

Summary

A completed cohort study evaluating high-dose daptomycin (>6 mg/kg/day) as salvage therapy for complex bone and joint infections at a regional reference center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Daptomycin (daptomycin)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Bone and Joint Infection, Treated by Daptomycin | Status: COMPLETED